Alerts will be sent to your verified email
Verify Email
CONCORD
|
Concord Drugs
|
Denis Chem Lab
|
Aptus Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
2.78 % | 9.47 % | 36.58 % |
|
5yr average Equity Multiplier
|
1.87 | 1.4 | 5.05 |
|
5yr Average Asset Turnover Ratio
|
0.84 | 1.46 | 1.72 |
|
5yr Avg Net Profit Margin
|
1.59 % | 4.57 % | 6.16 % |
|
Price to Book
|
3.22 | 1.23 | 15.79 |
|
P/E
|
193.0 | 15.16 | 35.63 |
|
5yr Avg Cash Conversion Cycle
|
233.27 Days | 5.37 Days | 88.73 Days |
|
Inventory Days
|
152.22 Days | 23.69 Days | 64.83 Days |
|
Days Receivable
|
106.22 Days | 65.58 Days | 65.8 Days |
|
Days Payable
|
74.71 Days | 89.52 Days | 77.01 Days |
|
5yr Average Interest Coverage Ratio
|
1.69 | 17.08 | 6.23 |
|
5yr Avg ROCE
|
8.41 % | 13.68 % | 28.46 % |
|
5yr Avg Operating Profit Margin
|
9.1 % | 10.7 % | 10.95 % |
|
5 yr average Debt to Equity
|
0.55 | 0.05 | 2.26 |
|
5yr CAGR Net Profit
|
-26.55 % | 29.02 % | 74.79 % |
|
5yr Average Return on Assets
|
1.46 % | 6.85 % | 8.44 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
54.39 % | 38.98 % | 72.89 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
5.39 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Concord Drugs
|
Denis Chem Lab
|
Aptus Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|